SEVİNDİK, Ö. G. Et Al. 2015. HYPOALBUMINEMIA IS A SURROGATE BIOMARKER OF POORPROGNOSIS IN MYELODYSPLASTIC SYNDROME EVEN WHENADJUSTED WITH COMORBIDITIES. 13th International Symposium on Myelodyspastic Syndromes / , 123.

SEVİNDİK, Ö. G., Güç, Z., KAHRAMAN, S., Medini, Ş., Katgı, A., ACAR, C., ... ALACACIOĞLU, İ.(2015). HYPOALBUMINEMIA IS A SURROGATE BIOMARKER OF POORPROGNOSIS IN MYELODYSPLASTIC SYNDROME EVEN WHENADJUSTED WITH COMORBIDITIES . 13th International Symposium on Myelodyspastic Syndromes / (pp.123).

SEVİNDİK, ÖMÜR Et Al. "HYPOALBUMINEMIA IS A SURROGATE BIOMARKER OF POORPROGNOSIS IN MYELODYSPLASTIC SYNDROME EVEN WHENADJUSTED WITH COMORBIDITIES," 13th International Symposium on Myelodyspastic Syndromes /, 2015

SEVİNDİK, ÖMÜR G. Et Al. "HYPOALBUMINEMIA IS A SURROGATE BIOMARKER OF POORPROGNOSIS IN MYELODYSPLASTIC SYNDROME EVEN WHENADJUSTED WITH COMORBIDITIES." 13th International Symposium on Myelodyspastic Syndromes / , pp.123, 2015

SEVİNDİK, Ö. G. Et Al. (2015) . "HYPOALBUMINEMIA IS A SURROGATE BIOMARKER OF POORPROGNOSIS IN MYELODYSPLASTIC SYNDROME EVEN WHENADJUSTED WITH COMORBIDITIES." 13th International Symposium on Myelodyspastic Syndromes / , p.123.

@conferencepaper{conferencepaper, author={ÖMÜR GÖKMEN SEVİNDİK Et Al. }, title={HYPOALBUMINEMIA IS A SURROGATE BIOMARKER OF POORPROGNOSIS IN MYELODYSPLASTIC SYNDROME EVEN WHENADJUSTED WITH COMORBIDITIES}, congress name={13th International Symposium on Myelodyspastic Syndromes /}, city={}, country={}, year={2015}, pages={123} }